
Patritumab Deruxtecan Continues to Show Encouraging Clinical Activity in Distinct Patient Populations with Metastatic ...
Updated results from phase 1 trial, including first presentation of data from a cohort of patients with EGFR-mutated metastatic non-small cell lung cancer, featured during a Presidential Session at JSMO Subgroup analysis by HER2 expression from phase 1…